2,335 Shares in Johnson & Johnson (NYSE:JNJ) Acquired by Fielder Capital Group LLC

Key Points

• Fielder Capital Group LLC acquired 2,335 shares of Johnson & Johnson, valued at approximately $387,000, during the first quarter, indicating ongoing institutional investment interest in the company.
• Johnson & Johnson's stock recently saw a 1.1% increase, reaching $168.03, while the company reported earnings per share of $2.77, exceeding analysts' expectations.
• The company declared a quarterly dividend of $1.30 per share, which will be paid on September 9th, reflecting a dividend yield of 3.09%.

Fielder Capital Group LLC acquired a new position in shares of Johnson & Johnson (NYSE:JNJ - Free Report) in the first quarter, according to its most recent disclosure with the SEC. The firm acquired 2,335 shares of the company's stock, valued at approximately $387,000.

A number of other hedge funds also recently added to or reduced their stakes in JNJ. Conquis Financial LLC acquired a new stake in shares of Johnson & Johnson in the 4th quarter valued at approximately $33,000. Bernard Wealth Management Corp. acquired a new stake in shares of Johnson & Johnson in the 4th quarter valued at approximately $36,000. Highline Wealth Partners LLC lifted its holdings in shares of Johnson & Johnson by 51.8% in the 1st quarter. Highline Wealth Partners LLC now owns 252 shares of the company's stock valued at $42,000 after buying an additional 86 shares during the period. von Borstel & Associates Inc. acquired a new stake in shares of Johnson & Johnson in the 1st quarter valued at approximately $49,000. Finally, Capital A Wealth Management LLC acquired a new stake in shares of Johnson & Johnson in the 4th quarter valued at approximately $50,000. 69.55% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have recently commented on JNJ shares. Sanford C. Bernstein reissued a "market perform" rating on shares of Johnson & Johnson in a report on Wednesday, April 16th. Wall Street Zen cut Johnson & Johnson from a "strong-buy" rating to a "buy" rating in a report on Friday, July 18th. Erste Group Bank raised Johnson & Johnson from a "hold" rating to a "buy" rating in a report on Wednesday, July 23rd. Guggenheim reaffirmed a "neutral" rating and set a $167.00 price objective (up from $164.00) on shares of Johnson & Johnson in a report on Thursday, July 17th. Finally, Royal Bank Of Canada lifted their price objective on Johnson & Johnson from $181.00 to $185.00 and gave the stock an "outperform" rating in a report on Thursday, July 17th. Nine analysts have rated the stock with a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $174.50.

Johnson & Johnson Trading Up 1.5%

JNJ stock traded up $2.39 during trading on Friday, reaching $167.13. 3,980,706 shares of the stock traded hands, compared to its average volume of 9,040,578. The business's 50 day moving average price is $157.18 and its 200-day moving average price is $156.44. Johnson & Johnson has a 52-week low of $140.68 and a 52-week high of $169.99. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.01 and a quick ratio of 0.76. The firm has a market capitalization of $402.52 billion, a PE ratio of 17.90, a P/E/G ratio of 2.13 and a beta of 0.41.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last issued its quarterly earnings data on Wednesday, July 16th. The company reported $2.77 EPS for the quarter, topping analysts' consensus estimates of $2.68 by $0.09. Johnson & Johnson had a return on equity of 32.49% and a net margin of 25.00%. The company had revenue of $23.74 billion for the quarter, compared to analysts' expectations of $22.85 billion. During the same quarter in the previous year, the firm posted $2.82 earnings per share. The firm's quarterly revenue was up 5.8% on a year-over-year basis. As a group, sell-side analysts forecast that Johnson & Johnson will post 10.58 earnings per share for the current year.

Johnson & Johnson Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 9th. Stockholders of record on Tuesday, August 26th will be issued a dividend of $1.30 per share. The ex-dividend date of this dividend is Tuesday, August 26th. This represents a $5.20 annualized dividend and a dividend yield of 3.1%. Johnson & Johnson's dividend payout ratio is 55.61%.

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.